Studying immune cells in head and neck and breast cancer
Part of Cancer, Skin clinical trials.
This study looks at tissue samples from patients who had surgery for head and neck or breast cancer. Researchers want to understand how certain immune cells in the tumor might affect the cancer, which could help improve treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older
- You have been diagnosed with either head and neck cancer or breast cancer
- You have already had surgery to remove the cancer
- Your medical records are available for the study
- You are willing to sign a consent form to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system and cancer cells interact. It may help doctors understand your cancer better and could lead to new treatments.
This study looks at tumor samples from people with head and neck cancer to understand why some treatments stop working. By studying the tumor tissue, researchers hope to find better ways to treat this cancer in the future.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks at why some head and neck cancers come back after treatment. It will test tumor tissue from people having surgery to see if certain proteins (mutant p53 and YAP) are linked to treatment resistance. Your participation could help researchers understand how to better treat these cancers in the future.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.